Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The ...

Currently, recommendations for cancer screening are primarily based on the age of the patient. Therefore, practitioners may ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, ...

EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...

The firms hope to show that Verdi's off-the-shelf peptide cancer vaccine can shrink tumors and improve quality of life in patients with bone metastases.

While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

Oct. 17, 2024 — Scientists developed a way of using artificial intelligence to check for skin cancer with the AI tool ... Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer ...

The use of AI applications in medical care is growing. Dr. Leana Wen explains the uses of AI that could improve care — and the reasons for continued caution.

We recently published a list of 10 Stocks To Trade Without Tariffs And Interest Rate Fears. In this article, we are going to take a look at where Moderna, Inc.